Kepler Capital Remains a Buy on arGEN X (0QW0)
at www.tipranks.com (Fri, 28-Feb 8:47 PM)
Argenx Earnings Call: Growth and Future Prospects
at www.tipranks.com (Fri, 28-Feb 7:55 PM)
at www.tipranks.com (Fri, 28-Feb 8:50 AM)
Oppenheimer Sticks to Its Buy Rating for Argenx Se (ARGX)
at www.tipranks.com (Fri, 28-Feb 8:25 AM)
Argenx Se (ARGX) Gets a Buy from Scotiabank
at www.tipranks.com (Fri, 28-Feb 8:17 AM)
Argenx Se: Promising Outlook with Vyvgart Momentum and Pipeline Expansion Justifies Buy Rating
at www.tipranks.com (Fri, 28-Feb 4:57 AM)
Argenx Reports Strong 2024 Financial Results and Strategic Growth
at www.tipranks.com (Thu, 27-Feb 11:42 PM)
Argenx Se: Strong Financial Performance and Promising Growth Prospects Drive Buy Rating
at www.tipranks.com (Thu, 27-Feb 5:45 PM)
Argenx’s VYVGART Franchise Drives Strong Performance and Growth Prospects
at www.tipranks.com (Thu, 27-Feb 3:55 PM)
argenx targets 12,000 CIDP patients with VYVGART expansion in 2025
at seekingalpha.com (Thu, 27-Feb 3:17 PM)
Analysts Offer Insights on Healthcare Companies: Lantheus (LNTH) and Argenx Se (ARGX)
at www.tipranks.com (Thu, 27-Feb 8:40 AM)
Argenx SE Reports Strong 2024 Financial Results and Advances Vision 2030
at www.tipranks.com (Thu, 27-Feb 7:00 AM)